Diabetes.co.uk: US trial to commence over insulin price hike lawsuit

By: Benedict Jephcote

The increasing cost of insulin is in the spotlight as a “groundbreaking” lawsuit in the US has been filed against three major pharmaceutical companies.

A group of people with diabetes, some of whom claim they are spending $900 (£710) a month on the hormone which is needed to control the condition, have decided to take legal action.

Eli Lilly, Novo Nordisk, and Sanofi have been accused of working together to raise the price of insulin to “skyrocketing prices”.

Read More…